View Author
patient thrombosis study budd-chiari syndrome liver bcs patients factor syndrome portal level treatment budd-chiari mutation survival diagnosis disorder hepatic blood jak 2v portal vein thrombosis result venou anticoagulation control signi ficantly transplantation signi hepatology disease month analysis ascite hospital splanchnic vein thrombosis venous thrombosis portal vein obstruction follow-up plasma number therapy outcome rotterdam shunt inhibitor portosystemic range table score recanalization cell transplantation erasmus mc prognostic group valla hemoglobinuria myeloproliferative value intrahepatic failure activity brinogen transjugular jak 2 mutation ficantly brinolytic risk factor fi brinogen protein volume university imaging liver transplantation procedure hepatic vein thrombosis anticoagulation therapy fxiii pvt patients t-pa antigen portal hypertension
8 Most Recent Publications
|
Good long-term outcome of Budd-Chiari syndrome with a step-wise management
(Article)
Seijo, S. Plessier, A. Darwish Murad, S. Heller, J. Hadengue, A. Primignani, M. Elias, E. Janssen, H.L.A. Valla, D.C. Garcia-Pagan, J.C. Hoekstra, J.W. Dell'Era, A. Mandair, D. Rifai, K. Trebicka, J. Morard, I. Lasser, L. Abraldes, J.G. |
2013-05-01
|
|
The JAK2 46/1 haplotype in Budd-Chiari syndrome and portal vein thrombosis
(Article)
Smalberg, J.H. Koehler, E. Janssen, H.L.A. Leebeek, F.W.G. Murad, S.D. Plessier, A. Seijo, S. Trebicka, J. Primignani, M. Maat, M.P.M. de García-Pagán, J.C. Valla, D.C. |
2011-04-14
|
|
Impaired fibrinolysis as a risk factor for Budd-Chiari syndrome
(Article)
Hoekstra, J. Guimarães, A.H.C. Primignani, M. Garcia-Pagan, J.C. Valla, D.C. Rijken, D.C. Janssen, H.L.A. Leebeek, F.W.G. Murad, S.D. Malfliet, J.J.M.C. Plessier, A. Hernandez-Guerra, M. Langlet, P. Elias, E. Trebicka, J. |
2010-01-14
|
|
Acute portal vein thrombosis unrelated to cirrhosis: A prospective multicenter follow-up study
(Article)
Plessier, A. Darwish Murad, S. Denninger, M.H. Vidaud, D. Condat, B. Hadengue, A. Primignani, M. Garcia-Pagan, J.C. Janssen, H.L.A. Valla, D.C. Hernandez-Guerra, M. Consigny, Y. Fabris, F. Trebicka, J. Heller, J. Morard, I. Lasser, L. Langlet, P. |
2010-01-01
|
|
Paroxysmal nocturnal hemoglobinuria in Budd-Chiari Syndrome: Findings from a cohort study
(Article)
Hoekstra, J. Leebeek, F.W.G. Garcia-Pagan, J.C. Valla, D.C. Janssen, H.L.A. Plessier, A. Raffa, S. Murad, S.D. Heller, J. Hadengue, A. Chagneau, C. Elias, E. Primignani, M. |
2009-10-01
|
|
Etiology, management, and outcome of the Budd-Chiari syndrome
(Article)
Murad, S.D. Plessier, A. Hadengue, A. Langlet, P. Miranda, H. Primignani, M. Elias, E. Leebeek, F.W.G. Rosendaal, F.R. Garcia-Pagan, J.C. Valla, D.C. Janssen, H.L.A. Hernandez-Guerra, M. Fabris, F. Eapen, C.E. Bahr, M.J. Trebicka, J. Morard, I. Lasser, L. Heller, J. |
2009-01-01
|
|
TIPS for Budd-Chiari Syndrome: Long-Term Results and Prognostics Factors in 124 Patients
(Article)
Garcia-Pagan, J.C. Heydtmann, M. Luca, A. Primignani, M. Janssen, H.L.A. Valla, D.C. Elias, E. Bosch, J.L. Raffa, S. Plessier, A. Murad, S.D. Fabris, F. Vizzini, G. Abraldes, J.G. Olliff, S. Nicolini, A. |
2008-09-01
|
|
The impact of JAK2 and MPL mutations on diagnosis and prognosis of splanchnic vein thrombosis: A report on 241 cases
(Article)
Kiladjian, J.J. Cervantes, F. Raffa, S. Janssen, H.L.A. Gardin, C. Cereja, S. Tonetti, C. Giraudier, S. Condat, B. Casadevall, N. Fenaux, P. Valla, D.C. Leebeek, F.W.G. Marzac, C. Cassinat, B. Chevret, S. Cazals-Hatem, D. Plessier, A. Garcia-Pagan, J.C. Murad, S.D. |
2008-05-15
|